Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 1
2006 2
2007 2
2008 1
2009 1
2010 4
2011 4
2013 4
2014 5
2015 2
2016 4
2017 1
2018 4
2019 1
2020 2
2021 3
2022 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT).
Kratochwil C, Fendler WP, Eiber M, Hofman MS, Emmett L, Calais J, Osborne JR, Iravani A, Koo P, Lindenberg L, Baum RP, Bozkurt MF, Delgado Bolton RC, Ezziddin S, Forrer F, Hicks RJ, Hope TA, Kabasakal L, Konijnenberg M, Kopka K, Lassmann M, Mottaghy FM, Oyen WJG, Rahbar K, Schoder H, Virgolini I, Bodei L, Fanti S, Haberkorn U, Hermann K. Kratochwil C, et al. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2830-2845. doi: 10.1007/s00259-023-06255-8. Epub 2023 May 29. Eur J Nucl Med Mol Imaging. 2023. PMID: 37246997 Free PMC article.
Advances in Peptide Receptor Radionuclide Therapy.
Sabet A, Biersack HJ, Ezziddin S. Sabet A, et al. Semin Nucl Med. 2016 Jan;46(1):40-6. doi: 10.1053/j.semnuclmed.2015.09.005. Semin Nucl Med. 2016. PMID: 26687856 Review.
The translation of somatostatin-receptor antagonists into human application represents another major source of significant improvement in terms of PRRT's benefit-toxicity ratio. Eventually, it may not be completely unlikely to see another radiopharmaceutical being regarded …
The translation of somatostatin-receptor antagonists into human application represents another major source of significant improvement in te …
Striatal dopamine transporters and cognitive function in Parkinson's disease.
Stögbauer J, Rosar F, Dillmann U, Faßbender K, Ezziddin S, Spiegel J. Stögbauer J, et al. Acta Neurol Scand. 2020 Oct;142(4):385-391. doi: 10.1111/ane.13320. Epub 2020 Aug 5. Acta Neurol Scand. 2020. PMID: 32914881
BACKGROUND: Idiopathic Parkinson's disease (PD) is characterized by clinical motor symptoms including hypokinesia, rigidity and tremor. ...METHODS: Fifty-four PD patients underwent [(123)I]FP-CIT SPECT and CERAD (Consortium to Establish a Registry for Alzheimer's Di …
BACKGROUND: Idiopathic Parkinson's disease (PD) is characterized by clinical motor symptoms including hypokinesia, rigidity and tremo …
Reduced MIBG accumulation of the parotid and submandibular glands in idiopathic Parkinson's disease.
Haqparwar J, Pepe A, Fassbender K, Dillmann U, Ezziddin S, Schaefer A, Leppert D, Spiegel J. Haqparwar J, et al. Parkinsonism Relat Disord. 2017 Jan;34:26-30. doi: 10.1016/j.parkreldis.2016.10.011. Epub 2016 Oct 15. Parkinsonism Relat Disord. 2017. PMID: 27769648
INTRODUCTION: Alpha-synuclein pathology (ASP) is a characteristic histopathological finding in idiopathic Parkinson's disease (PD). The ASP involves not only the brain but also extracranial structures. ...
INTRODUCTION: Alpha-synuclein pathology (ASP) is a characteristic histopathological finding in idiopathic Parkinson's disease (PD). T …
Systemic Mastocytosis Treatment with Midostaurin: [18F]FDG PET/CT as a Potential Monitoring Tool for Therapy Outcome.
Burgard C, Rosar F, Khreish F, Ezziddin S. Burgard C, et al. Diagnostics (Basel). 2022 Mar 10;12(3):680. doi: 10.3390/diagnostics12030680. Diagnostics (Basel). 2022. PMID: 35328232 Free PMC article.
Post-therapeutic [(18)F]FDG PET/CT showed decreased multifocal tracer uptake in the known lesions in the gastrointestinal tract, which was consistent with relief of the patient's symptoms and decrease in serum tryptase level. [(18)F]FDG PET/CT may thus be considered a pote …
Post-therapeutic [(18)F]FDG PET/CT showed decreased multifocal tracer uptake in the known lesions in the gastrointestinal tract, which was c …
[Neuroendocrine Neoplasia within the German NET Registry].
Im Namen aller Teilnehmer/innen am Deutschen NET-Registers; Authors; Kollaboratoren:. Im Namen aller Teilnehmer/innen am Deutschen NET-Registers, et al. Z Gastroenterol. 2018 Oct;56(10):1237-1246. doi: 10.1055/a-0661-6099. Epub 2018 Oct 10. Z Gastroenterol. 2018. PMID: 30304748 German.
42 results